CWIG
ABBV icon

Chung Wu Investment Group’s AbbVie ABBV Stock Holding History

Chung Wu Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Sell
6,695
-250
-4% -$53.8K 1.11% 22
2026
Q1 		$1.51M Sell
6,945
-1,400
-17% -$311K 1.3% 18
2025
Q4 		$1.91M Buy
8,345
+1,500
+22% +$342K 1.56% 13
2025
Q3 		$1.58M Sell
6,845
-20
-0.3% -$4.07K 1.32% 16
2025
Q2 		$1.27M Sell
6,865
-2,360
-26% -$439K 1.33% 16
2025
Q1 		$1.93M Buy
9,225
+1,380
+18% +$268K 2.31% 11
2024
Q4 		$1.39M Buy
+7,845
New +$1.44M 1.4% 18

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Chung Wu Investment Group's ABBV Position: Q2 2026 in Review

Chung Wu Investment Group reduced its AbbVie (ABBV) stake by 3.6% in Q2 2026, selling an estimated $53.8K and leaving 6,695 shares worth $1.68M. The position accounts for 1.11% of the portfolio, ranked #22.

Chung Wu Investment Group first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.93M in Q1 2025. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Chung Wu Investment Group held 6,695 shares of AbbVie worth $1.68M as of Q2 2026.
  • Chung Wu Investment Group sold 250 AbbVie shares in Q2 2026, an estimated $53.8K.
  • AbbVie made up 1.11% of Chung Wu Investment Group's portfolio in Q2 2026, its #22 holding.
  • Chung Wu Investment Group first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Chung Wu Investment Group's AbbVie position peaked at $1.93M in Q1 2025.
  • 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Chung Wu Investment Group's 13F filing for Q2 2026, filed 31 Jul 2026.